What is Microbot Medical's D&A?

Microbot Medical (MBOT) reported D&A of $12K in Q1 2026.

How has Microbot Medical's D&A changed year-over-year?

Microbot Medical's D&A decreased by 20.0% year-over-year, from $15K to $12K.

What is the long-term trend for Microbot Medical's D&A?

Over 4 years (2021 to 2025), Microbot Medical's D&A has grown at a -11.3% compound annual growth rate (CAGR), from $76K to $47K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Microbot Medical MBOT D&A

D&A at other companies

MedtronicMDT

$716M-14.8%

AngioDynamicsANGO

$5.59M-11.5%

ITG

Integer HoldingsITGR

$35.01M+17.4%

Merit Medical SystemsMMSI

$30.5M+4.1%

StereotaxisSTXS

$159K+1.9%

TFX

TeleflexTFX

$19.85M+52.3%

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's D&A?: Microbot Medical (MBOT) reported D&A of $12K in Q1 2026.
How has Microbot Medical's D&A changed year-over-year?: Microbot Medical's D&A decreased by 20.0% year-over-year, from $15K to $12K.
What is the long-term trend for Microbot Medical's D&A?: Over 4 years (2021 to 2025), Microbot Medical's D&A has grown at a -11.3% compound annual growth rate (CAGR), from $76K to $47K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.